D r. George Tidmarsh, the FDA drug regulator who was placed on leave and complained of a “toxic” work environment in an ...

A pharmaceutical company has initiated a voluntary recall of more than half a million bottles of its blood pressure ...

Phio Pharmaceuticals shares were higher after the company reported positive pathology results for its Phase 1b Intasyl PH-762 trial. The stock was 32% higher, at $2.72. Shares are up 55% year to date.

Aging populations and clearer U.S. drug pricing boost long-term pharma outlook. Leaders like Eli Lilly and Merck lead in ...

Industry leaders say uncertainty in funding, clinical development and manufacturing is driving companies to embrace digital ...

This article originally appeared on MyCentralJersey.com: Global pharmaceutical firm chooses Bridgewater for new corporate ...

These companies are investing heavily into their pipelines and the payoff for long-term investors can be substantial.

Terns Pharmaceuticals shares jumped after the company shared positive data for its leukemia treatment TERN-701. The stock gained 83% to $15.09 on Monday, putting it on track for its highest close ...

Three pharma companies that have delivered the highest average 5-year ROCE are all into manufacturing the same type of ...

AstraZeneca, Eli Lilly and Merck committed $120 million to develop an advanced pharmaceutical manufacturing training center in Central Virginia.

The reporting duo demonstrate how drugmakers exploit public funding and legal loopholes to turn high profits, while ...

KDEV) today announces that its portfolio company BOOST Pharma has raised a SEK 34 million investment structured as a tranched convertible loan from Sound Bioventures.The investment supports continued ...